Orthopic reconstituted human breast tumor model in mouse

Details for Australian Patent Application No. 2005314003 (hide)

International Classifications

Event Publications

19 July 2007 PCT application entered the National Phase

PCT publication WO2006/063182 Priority application(s): WO2006/063182

7 April 2011 Application Accepted

Published as AU-B-2005314003

28 July 2011 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 06 Jul 2011. Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000 2006 2006204258 1-thio-D-glucitol derivatives Taisho Pharmaceutical Co., Ltd. The nature of the amendment is as shown in the statement(s) filed 22 Jun 2011. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

17 November 2011 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 06 Jul 2011 2006

24 November 2011 Standard Patent Sealed

24 November 2011 Corrigenda

Applications Accepted - Name Index Under the name AVEO Pharmaceuticals, Inc., Application No. 2005314003, under INID (72) correct the co-inventor to Robinson, Murray O.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.